- Abbott Laboratories, USA
- Amit Ltd., Israel
- Anterios, Inc. USA
- Argentis, LLC, USA
- Barrier Therapeutics, Inc., USA
- Biomimetic Pharmaceuticals, USA
- Children's Hospital and Regional Medical Center (NIH Grant), USA
- Cleveland Clinic, USA
- Devirex, LTD, Switzerland
- Digestive Care Inc., USA
- ExSAR Corporation, USA
- Ferring Pharmaceuticals, Denmark/Holland / USA / Canada
- GalMed, Ltd, Israel
- HRA Pharmaceuticals, France
- Infacare Pharmaceuticals, USA
- Jerini, AG, Germany
- Lifebond, Ltd. Israel
- Luitpold Pharmaceuticals, USA
- Mediwound Ltd., Israel
- Meditor Ltd., Israel
- Morria Pharmaceuticals, England
- NST, Ltd., Israel
- Ortek, Inc., USA
- Pfizer Pharmaceuticals, USA
- Pluristem, LTD., Israel
- Polyheal, Ltd., Israel
- Prochon, Ltd., Israel
- Prometheus Laboratories, USA
- Protalix, Ltd., Israel
- Regeneron Pharmaceuticals, USA
- Samyang Pharmaceuticals, Korea
- Se-Cure Pharmaceuticals, Israel
- Stanford University (HHS government grant) , USA
- Summers Laboratories, USA
- Synthemed, Inc., USA
- Thrombotech, LTD, Israel
- TransPharma, Ltd., Israel
- Vicor Technologies, Inc., USA
Asian Clinical Trial Network
Target Health Inc. is a founding member of Asian Clinical Trial Network (ACTN).
The ACTN is a consortium of CROs and clinical study sites, committed to the implementation
and execution of GCP clinical trials in Asia. Click here for a brochure.
|